NIH-funded research NIH-funded research

Exercise training for people with heart failure with preserved ejection fraction (HFpEF)

Official title: Efficacy of exercise training in patients with HFpEF

Funded at VA Salt Lake City Healthcare System · NIH-11329777 · Data updated 2026-11-12

This project tests whether blocking specific muscle nerve signals with a spinal fentanyl injection changes circulation, muscle fatigue, and exercise ability in people with HFpEF compared with healthy controls.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Salt Lake City Healthcare System
NIH-funded
Lab location1 site (Salt Lake City, United States)
Project startOctober 1, 2020
Project endSeptember 30, 2026
Funding year2026
NIH project number5I01RX003343-06
Project IDNIH-11329777 on NIH RePORTER

Who could benefit from this research

Could help

Adults diagnosed with HFpEF who experience exercise intolerance and are medically stable and willing to undergo lumbar intrathecal injection, MRI, and exercise testing would be ideal candidates.

Less likely to help

People with reduced ejection fraction heart failure, unstable medical conditions, contraindications to spinal injections or MRI, or who cannot perform exercise testing are unlikely to be eligible or directly helped by this protocol.

What this research studies

If you join, you would perform supervised voluntary and passive exercise sessions while researchers measure your blood flow, blood pressure reflexes, and muscle fatigue. At times you would receive a small lumbar intrathecal fentanyl injection to temporarily block certain muscle nerve signals so the team can compare exercise with and without that feedback. They will use femoral nerve stimulation to measure central and peripheral fatigue and 31-phosphorus MR spectroscopy of the thigh muscle to look at metabolic changes during exercise. Results from people with HFpEF will be compared to well-matched healthy volunteers to pinpoint what contributes to exercise intolerance.

Why it matters

Potential benefit: The findings could point to new ways to reduce fatigue and improve exercise tolerance for people with HFpEF.

How similar studies have gone: Blocking group III/IV muscle afferents with intrathecal fentanyl has been used in prior human studies to change exercise responses, but applying this approach specifically to HFpEF is relatively new.

Where this research is happening

  • VA Salt Lake City Healthcare System
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Amann, Markus — VA Salt Lake City Healthcare System
  • Study coordinator: Amann, Markus

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.